Search Results 1791-1800 of 15587 for Orange Peel tea

1. Zagociguat In Participants With Melas (Prizm) - Mayo Clinic

   The purpose of this study is to evaluate the effects of zagociguat on fatigue and cognition in patients with MELAS. Participation eligibility. Participant ...

2. Paclitaxel, Ifosfamide And Cisplatin (TIP) Versus Bleomycin, Etoposide And Cisplatin (BEP) For Patients With Previously Untreated Intermediate- And Poor-risk Germ Cell Tumors - Mayo Clinic

   except for non-melanoma skin cancer. Patients known to be HIV positive and receiving HAART; Presence of an active infection. Patients with fever assessed to be ...

3. A Study to Analyze CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. Selinexor, Daratumumab, Carfilzomib And Dexamethasone For The Treatment Of High-Risk, Recurrent Or Refractory Multiple Myeloma - Mayo Clinic

   - Non-melanoma skin cancer - In situ malignancy - Low-risk prostate cancer after curative therapy - Prostate cancer Gleason grade 6 AND with stable prostate ...

5. A Study To Evaluate PRM-151 In Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

   History of a malignancy within the 5 years prior to screening, with the exception of basal cell or squamous cell skin neoplasms. In addition, a malignant ...

6. Efficacy And Safety Of IV Rigosertib In MDS Patients With Excess Blasts Progressing After Azacitidine Or Decitabine - Mayo Clinic

   This study will examine the effect intravenously administered rigosertib has on the relationship between bone marrow blasts response and overall survival in ...

7. Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

   About this study. This phase II trial studies how well combination chemotherapy and pralatrexate works in treating patients with non-Hodgkin lymphoma (NHL).

8. Study Of GS-5290 In Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. A Phase 1-2 Multi-Center Study Evaluating Axicabtagene Ciloleucel In Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) - Mayo Clinic

   Participation eligibility · History of malignancy other than nonmelanoma skin cancer or carcinoma in situ (e.g., cervix, bladder, breast) or follicular lymphoma ...

10. SX-682 Treatment In Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab - Mayo Clinic

    Prior malignancy active within the previous 3 years except for locally curable cancers that have been apparently cured, such as basal or squamous cell skin ...